Saturday, April 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

ASML’s Record Forecast Meets a Reality Check as Margins Dip and Order Details Vanish

Jackson Burston by Jackson Burston
April 25, 2026
in Earnings, European Markets, Semiconductors, Tech & Software
0
Asml Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

ASML delivered a standout first-quarter performance, raised its full-year outlook, and rewarded shareholders with a bigger dividend — yet the stock ended the week lower than where it started. The disconnect between operational strength and market sentiment has rarely been more pronounced for the Dutch lithography giant.

The company posted net sales of €8.8 billion for the first quarter of 2026, a 13% year-on-year increase, alongside a net profit of €2.8 billion. Earnings per share of €7.15 beat analyst expectations, but the shares initially slumped more than 7% following the release before recovering some ground. The market, it appears, had already priced in the good news.

What unsettled investors was not the headline numbers but what lay beneath. ASML guided for a second-quarter gross margin of 51% to 52%, a noticeable step down from the 53% achieved in Q1. That margin compression, combined with the company’s decision to withhold specific order intake figures for the first time, created an air of uncertainty around what is traditionally the most closely watched metric in the semiconductor equipment space. CEO Christophe Fouquet described order intake as “very strong” but offered no numbers to back that up.

A Shifting Geographic Mix and a New Productivity Boost

The composition of ASML’s sales shifted markedly in the quarter. EUV systems accounted for 66% of system revenue, up from 48% in the previous quarter. Geographically, the balance tilted sharply toward South Korea, which jumped to 45% of sales, while China’s share fell from 36% to 19% — a reflection of ongoing export restrictions and changing customer dynamics.

On the product front, ASML launched the NXE:3800E PEP-E, a productivity package for its best-selling EUV system that boosts throughput from 220 to 230 wafers per hour. The upgrade is particularly significant for the company’s high-margin services business, which generated more than double the entire research and development spend in the quarter.

Dividend, Buybacks, and a Board Refresh

Shareholders approved a final dividend of €2.70 per share at the annual general meeting on April 22, bringing the total payout for the 2025 financial year to €7.50 — a 17% increase from the prior year. The stock traded ex-dividend on April 24, with payment scheduled for May 5.

Should investors sell immediately? Or is it worth buying Asml?

The company’s €12 billion share buyback program, covering 2026 through 2028, is already underway. ASML repurchased €1.1 billion worth of shares in the first quarter alone, and the AGM authorized management to buy back up to 10% of issued capital.

In a management reshuffle, Marco Pieters was appointed chief technology officer, expanding the executive board to six members.

The Stock and the Long View

ASML shares closed at €1,240.80 on Friday, roughly 4% below their 52-week high of €1,295.00 but more than double their level a year ago. The relative strength index of 66 suggests slightly elevated momentum without signaling an overheated market. Since the start of 2025, the stock has gained nearly 25%.

The medium-term outlook remains robust. Memory and logic chip customers are increasing their capital expenditure budgets for 2026 and beyond, driven by AI demand and capacity constraints in the memory segment. ASML sees annual revenue potential of €44 billion to €60 billion by 2030, with gross margins between 56% and 60%. The company is also just beginning to ramp production of its next-generation High-NA EUV systems, which are essential for the most advanced chip fabrication and should cement ASML’s near-monopoly position for years to come.

For now, however, the market is focused on the near-term margin squeeze and the missing order data — a reminder that even the strongest fundamentals can face a skeptical audience when expectations run high.

Ad

Asml Stock: Buy or Sell?! New Asml Analysis from April 25 delivers the answer:

The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.

Asml: Buy or sell? Read more here...

Tags: ASML
Jackson Burston

Jackson Burston

Related Posts

BioNTech Stock
Earnings

BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds

April 25, 2026
Siemens Healthineers Stock
AI & Quantum Computing

Siemens Healthineers Hires a Google Brain Veteran as a 14 Billion Euro Debt Overhang Weighs on the Stock

April 25, 2026
DroneShield Stock
Cyber Security

DroneShield’s Record Cash Haul Masks a Tug-of-War Between Momentum and Skepticism

April 25, 2026
Next Post
Hensoldt Stock

Hensoldt’s Drone Training Milestone Fails to Lift a Stock in Freefall

Commerzbank Stock

Commerzbank’s Standalone Strategy Intensifies as BaFin Clamps Down on UniCredit

BayWa Stock

BayWa Faces a Pivotal Month as Asset Sales Falter and Legal Woes Deepen

Recommended

Electrocore Stock

Electrocore’s Strategic Growth Takes Center Stage for Investors

2 months ago
CrowdStrike Stock

CrowdStrike’s AI Security Surge: Institutional Confidence Meets Insider Selling

6 months ago
Ultragenyx Pharmaceutical Stock

Ultragenyx Stock: A Contrarian Opportunity Amidst Steep Declines?

7 months ago
Standard Lithium Stock

Standard Lithium Shares Face Crucial Investor Test

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Newmont Mining Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Allianz’s Two-Front War: Green Storage Expansion Meets a Bleak Insolvency Warning

Siemens Healthineers Hires a Google Brain Veteran as a 14 Billion Euro Debt Overhang Weighs on the Stock

Global Tech Titans Propel Vanguard’s $57 Billion ETF to the Brink of a New Record

TKMS: India’s Defence Minister Tours Kiel as Stock Sinks Below Key Level

BYD’s Nine-Minute Charge: Can Ultra-Fast Charging Reverse a Home Market Slide?

DroneShield’s Record Cash Haul Masks a Tug-of-War Between Momentum and Skepticism

Trending

BioNTech Stock
Earnings

BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds

by Jackson Burston
April 25, 2026
0

The rally in BioNTech shares this month has been one of the sector's standout stories, but a...

Gold Stock

Gold’s Dual Narrative: Fed Stability Meets Wall Street Skepticism

April 25, 2026
Renk Stock

Renk’s 100-Day Line Breach Fails as NATO Orders and Production Pivot Take Centre Stage

April 25, 2026
Allianz Stock

Allianz’s Two-Front War: Green Storage Expansion Meets a Bleak Insolvency Warning

April 25, 2026
Siemens Healthineers Stock

Siemens Healthineers Hires a Google Brain Veteran as a 14 Billion Euro Debt Overhang Weighs on the Stock

April 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds
  • Gold’s Dual Narrative: Fed Stability Meets Wall Street Skepticism
  • Renk’s 100-Day Line Breach Fails as NATO Orders and Production Pivot Take Centre Stage

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com